|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.54 USD | -0.42% |
|
-3.18% | -27.56% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 39.33 | 39.33 | 49.84 |
| Spread/Res. | -14.72% | -14.72% | -32.70% |
| Spread/Supp. | +10.04% | +10.04% | +11.54% |
| Support | 30.48 | 30.48 | 30.07 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- COLL Stock
- Charts Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
